Atlas Venture Life Science Advisors, LLC Long-Term Concentrated

Name: Atlas Venture Life Science Advisors, LLC Q2 2024 13F Filing | 13F Explorer
Creator: Atlas Venture Life Science Advisors, LLC
Published: 2024-08-09

Location: Cambridge, MA

CIK: 0001917529 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 9, 2024

Total Value: $950M (100.0% shares, 0.0% debt)

Holdings (15)

DYN Dyne Therapeutics, Inc. 29.8%

Value $283M Shares 8,020,136 Est. Cost $13.82 Unrealized +110.3%

KYMR Kymera Therapeutics, Inc. 16.8%

Value $160M Shares 5,350,422 Est. Cost $58.25 Unrealized -40.6%

— Third Harmonic Bio, Inc. 14.9%

Value $142M Shares 10,907,859 Est. Cost $18.97 Unrealized —

IRON Disc Medicine, Inc. 11.9%

Value $113M Shares 2,509,456 Est. Cost $48.39 Unrealized -29.8%

DAWN Day One Biopharmaceuticals, Inc. 9.3%

Value $88.61M Shares 6,430,257 Est. Cost $19.68 Unrealized -25.6%

KRRO Korro Bio, Inc. 4.1%

Value $38.52M Shares 1,137,149 Est. Cost $33.30 Unrealized +65.9%

QTTB Q32 Bio, Inc. 4.0%

Value $37.55M Shares 2,092,106 Est. Cost $13.78 Unrealized +73.6%

— Generation Bio, Co. 2.5%

Value $23.35M Shares 8,279,484 Est. Cost $7.08 Unrealized —

— Vigil Neuroscience, Inc. 2.5%

Value $23.35M Shares 5,836,874 Est. Cost $7.03 Unrealized —

REPL Replimune Group, Inc. 2.0%

Value $18.88M Shares 2,098,300 Est. Cost $29.91 Unrealized -76.7%

— Ikena Oncology, Inc. 0.9%

Value $8.28M Shares 5,018,178 Est. Cost $12.54 Unrealized —

TECX Tectonic Therapeutics, Inc. 0.7%

Value $6.233M Shares 378,447 Est. Cost $15.77 Unrealized 0.0%

DNTH Dianthus Therapeutics, Inc. 0.4%

Value $3.545M Shares 136,979 Est. Cost $12.62 Unrealized +90.5%

— Aerovate Therapeutics, Inc. 0.3%

Value $2.987M Shares 1,799,232 Est. Cost $11.88 Unrealized —

SPRO Spero Therapeutics, Inc. 0.1%

Value $696K Shares 535,336 Est. Cost $15.88 Unrealized -90.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
DYN	Dyne Therapeutics, Inc.	8,020,136	$283M	29.8%	$13.82	+110.3%	Common Stock	26818M108
KYMR	Kymera Therapeutics, Inc.	5,350,422	$160M	16.8%	$58.25	-40.6%	Common Stock	501575104
—	Third Harmonic Bio, Inc.	10,907,859	$142M	14.9%	$18.97	—	Common Stock	88427A107
IRON	Disc Medicine, Inc.	2,509,456	$113M	11.9%	$48.39	-29.8%	Common Stock	254604101
DAWN	Day One Biopharmaceuticals, Inc.	6,430,257	$88.61M	9.3%	$19.68	-25.6%	Common Stock	23954D109
KRRO	Korro Bio, Inc.	1,137,149	$38.52M	4.1%	$33.30	+65.9%	Common Stock	500946108
QTTB	Q32 Bio, Inc.	2,092,106	$37.55M	4.0%	$13.78	+73.6%	Common Stock	746964105
—	Generation Bio, Co.	8,279,484	$23.35M	2.5%	$7.08	—	Common Stock	37148K100
—	Vigil Neuroscience, Inc.	5,836,874	$23.35M	2.5%	$7.03	—	Common Stock	92673K108
REPL	Replimune Group, Inc.	2,098,300	$18.88M	2.0%	$29.91	-76.7%	Common Stock	76029N106
—	Ikena Oncology, Inc.	5,018,178	$8.28M	0.9%	$12.54	—	Common Stock	45175G108
TECX	Tectonic Therapeutics, Inc.	378,447	$6.233M	0.7%	$15.77	0.0%	Common Stock	878972108
DNTH	Dianthus Therapeutics, Inc.	136,979	$3.545M	0.4%	$12.62	+90.5%	Common Stock	252828108
—	Aerovate Therapeutics, Inc.	1,799,232	$2.987M	0.3%	$11.88	—	Common Stock	008064107
SPRO	Spero Therapeutics, Inc.	535,336	$696K	0.1%	$15.88	-90.5%	Common Stock	84833T103